-
How to use the EGA search box
Documentation
discovery/metadata/search-box
-
EGA synthetic data
Documentation
synthetic-data
-
What is the cBioPortal
Documentation
submission/metadata/submission/cbioportal
-
Submission FAQ
Documentation
submission/metadata/submission/FAQ
-
Federated EGA
Documentation
about/projects-and-funders/federated-ega
-
GA4GH
Documentation
about/projects-and-funders/ga4gh
-
Projects
Documentation
about/projects-and-funders/projects
-
Catalogue Statistics
Documentation
about/statistics/catalogue
-
Visium Spatial transcriptomic profiling of IOKIN samples
Study
EGAS50000002196
-
Bladder cancer genomic sequencing data from exclusive waterpipe tobacco smokers - AUBMC cohort
Study
EGAS50000002183
-
AUBMC Waterpipe Bladder Cancer Data Access Committee
Dac
EGAC50000001155
-
Whole-Exome Sequencing of Tumor Biopsies from a Colorectal Cancer Patient with Two Distinct Primary Tumors and Matched Metastases
Study
EGAS50000001385
-
Genomic correlates with survival after treatment of oesophageal adenocarcinoma by surgery alone
Dac
EGAC50000001177
-
Bladder Cancer Genomics Data Access Committee – Erlangen–Bonn Collaboration
Dac
EGAC50000001118
-
Aligned BAM files from targeted amplicon sequencing
Dataset
EGAD50000002861
-
Multiomic Analysis of Treatment Naive MYD88 Mutated Patients with Waldenstrom’s Macroglobulinemia
Study
EGAS50000002182
-
Multi-omics analysis revealed clonal evolution of the sarcoma patient-derived xenograft
Study
EGAS50000001860
-
Genomic sequencing in an oesophageal adenocarcinoma cohort
Dataset
EGAD50000003139
-
MEDIOLA WOO serial tumor RNA sequencing (raw reads)
Dataset
EGAD50000002906
-
MEDIOLA WOO baseline tumor and germline whole-exome sequencing (raw reads)
Dataset
EGAD50000002907
-
Whole-Exome Sequencing Analysis of Tumor Biopsies from a Colorectal Cancer Patient
Dataset
EGAD50000002011
-
Plasma CTCF ChIP-seq Reveals Cancer-Associated cfDNA Binding Profiles
Study
EGAS50000001937
-
METABRIC
Study
EGAS00000000083
-
Machine Learning Uncovers Previously Undetectable Genetic Deletions in Cancer Panel Sequencing
Study
EGAS00001008324
-
Gene expression profiling in pregnancy-associated breast cancer
Study
EGAS00001008013
-
Somatic mutations of non-malignant T cells
Study
EGAS50000000237
-
Spatial transcriptomic profiling of INSPIRE samples
Dataset
EGAD50000003130
-
Single-cell and spatial transcriptomic profiling of peritoneal metastasis of gastric cancer
Study
EGAS50000001875
-
TLS-associated B cell repertoire shaping and response to immune checkpoint inhibitors in patients with renal cell cancer
Study
EGAS50000002165
-
Structural Forms of ERBB2 Amplification and Their Clinical Significance in EAC Brain Metastases
Study
EGAS50000001593
-
Germline ALK variant in patient with neurodisability and neuroblastoma
Study
EGAS50000001885
-
Breast Cancer Association Consortium Data Access Coordinating Committee
Dac
EGAC50000000824
-
Comprehensive DNA and RNA profiling of relapsed interdigitating dendritic cell sarcoma in a patient achieving durable remission after autologous stem cell transplantation
Study
EGAS50000002220
-
WGS data from NeoPancOne trial
Dataset
EGAD50000002952
-
WTS data from NeoPancOne trial
Dataset
EGAD50000002953
-
Digital mRNA-seq FASTQ files from the PEGASUS colorectal cancer cohort
Dataset
EGAD50000002963
-
BIONIKK_Translational Research_Data Access Committee
Dac
EGAC50000001158
-
UNICORN trial ST
Study
EGAS50000002020
-
Whole genome sequencing data of high-grade serous ovarian cancer samples (set 18)
Dataset
EGAD50000002796
-
Spatial transcriptomic profiling of IOKIN samples
Dataset
EGAD50000003147
-
IMMUcan BC1 cohort
Study
EGAS50000001587
-
PEGASUS cohort transcriptomic profiling
Study
EGAS50000002062
-
IMMUcan SYNERGY BC1 cohort
Study
EGAS50000002010
-
Immune Biomarkers in Metastatic Castration-resistant Prostate Cancer
Study
EGAS50000001269
-
Immune heterogeneity in small cell lung cancer and vulnerability to immune checkpoint blockade
Study
EGAS50000000138
-
Synergy study: "Tissue resident CD8+ T cell clonal expansion in advanced triple negative breast cancer is associated with response to chemoimmunotherapy"
Study
EGAS50000000527
-
High grade serous ovarian cancer germline exome sequencing
Study
EGAS50000001730
-
Genomic Profiling of Rare Tumors
Study
phs003916
-
Center for Common Disease Genomics (CCDG) - Cardiovascular: Multiethnic Cohort
Study
phs003499
-
NCTN: An Intergroup Phase III Randomized Controlled Trial Comparing Melphalan, Prednisone and Thalidomide (MPT) vs Melphalan, Prednisone and Lenalidomide (Revlimid) (MPR) in Multiple Myeloma Patients Who Are Not Candidates for High-Dose Therapy (E1A06)
Study
phs004394
-
Lineage Heterogeneity and Plasticity in Lung Cancer
Study
phs004458
-
Genomics Studies of AML in Patients Older than 60 Years of Age (ECOG-ACRIN Cancer Research Group's Clinical Trial e3999)
Study
phs003773
-
The Discovery and Validation of AML Prognostic Biomarkers
Study
phs002805
-
Blood and Marrow Clinical Trials Network (BMT CTN) A Phase III Randomized, Multicenter Trial Comparing Sirolimus/Tacrolimus With Tacrolimus/Methotrexate as Graft-versus-Host Disease Prophylaxis After HLA-Matched, Related Peripheral Blood Stem Cell Transplantation (BMT-CTN-0402-BioLINCC)
Study
phs004629
-
NCTN: TAILORx: Program for the Assessment of Clinical Cancer Tests: Trial Assigning Individualized Options for Treatment (PACCT-1)
Study
phs004260
-
NCTN: A Randomized Phase III Trial of Three Different Regimens of CPT-11 Plus 5-Fluorouracil and Leucovorin Compared to 5-Fluorouracil and Leucovorin in Patients with Advanced Adenocarcinoma of the Colon and Rectum (N9741)
Study
phs004259
-
Germline Sequence Variation in Cancer Genes Among Rwandan Breast and Prostate Cancer Cases
Study
phs003927
-
HINTS Geo-Coded Data 2018 (HINTS 5 Cycle 2)
Study
phs004217
-
HINTS Geo-Coded Data 2012 (HINTS 4 Cycle 2)
Study
phs004207
-
A Randomized Phase 2 Study of Cabozantinib in Combination with Nivolumab in Advanced, Recurrent Metastatic Endometrial Cancer
Study
phs003414
-
Derivation of Doxorubicin Mutational Signatures in Cancer
Study
phs004740
-
Identifying and Understanding Drivers of Chemoresistance in Small Cell Lung Cancer
Study
phs004087
-
NCTN: A Randomized Phase III Comparison of Standard-Dose (60 Gy) versus High-Dose (74 Gy) Conformal Radiotherapy with Concurrent and Consolidation Carboplatin/Paclitaxel +/- Cetuximab in Patients with Stage IIIA/IIIB Non-Small Cell Lung Cancer (RTOG-0617)
Study
phs004191
-
Long-Read Sequencing of Ovarian Cancer Organoids
Study
phs004795
-
Open-Label, Phase I study of NeoVax with Nivolumab in Patients with Ovarian Cancer
Study
phs004380
-
Childhood Cancer Data Initiative (CCDI): A Cohort of Hispanic Children with Acute Lymphoblastic Leukemia; Bloom Syndrome in a Mexican American Family with Rhabdomyosarcoma
Study
phs002823
-
NCTN: A Phase III Trial in Adult Acute Myeloid Leukemia: Daunorubicin Dose-Intensification Prior to Risk-Allocated Autologous Stem Cell Transplantation (E1900)
Study
phs004393
-
The Vaginal Microbiome, Maternal Response, and Preterm Birth
Study
phs003875
-
NCTN: Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer (E5204)
Study
phs004621
-
Urine Cell-Free RNA Analysis for Cancer Detection and Therapy Response Prediction
Study
phs004116
-
Evaluation of the Effects of Endocrine Therapy and Abemaciclib on Host and Tumor Immune Cell Repertoire/Function in Advanced ER+/HER2- Breast Cancer
Study
phs004470
-
NCTN: A Phase 1/2 Study of CPX-351 (NSC# 775341) Alone followed by Fludarabine, Cytarabine, and G-CSF (FLAG) for Children with Relapsed Acute Myeloid Leukemia (AML) (AAML1421)
Study
phs004160
-
Human GPR15 Deficiency Reveals CD8+ T Regulatory Cell-Macrophage Crosstalk in Intestinal Inflammation
Study
phs003950
-
Transcriptional Profiling of a Dana-Farber Cancer Institute Early-Onset Colorectal Cancer Cohort
Study
phs004807
-
NCTN: A Phase III Randomized Trial for Patients with De Novo AML Using Bortezomib and Sorafenib (NSC# 681239, NSC# 724772) for Patients with High Allelic Ratio FLT3/ITD (AAML1031)
Study
phs004142
-
NCTN: Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor (AREN0532)
Study
phs004139
-
HINTS Geo-Coded Data 2014 (HINTS 4 Cycle 4)
Study
phs004209
-
NCTN: A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node (ACOSOG-Z0011)
Study
phs004234
-
Blood and Marrow Clinical Trials Network (BMT CTN) Comparing Peripheral Blood Stem Cell Transplantation versus Bone Marrow Transplantation in Individuals With Hematologic Cancers (0201) (BMT-CTN-BioLINCC)
Study
phs004601
-
NCTN: A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients with Advanced Transitional Cell Carcinoma (CALGB-90601)
Study
phs004243
-
NCTN: A Randomized, Phase III Study Comparing Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab with or without Concurrent Cetuximab in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) (S0819)
Study
phs004231
-
NCORP: Vitamin D and Breast Cancer Biomarkers (CALGB-70806)
Study
phs004250
-
NCTN: A Randomized Phase III Study of Ibrutinib (PCI-32765)-Based Therapy vs Standard Fludarabine, Cyclophosphamide, and Rituximab (FCR) Chemoimmunotherapy in Untreated Younger Patients With Chronic Lymphocytic Leukemia (CLL) (E1912)
Study
phs004233
-
NCTN: A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients With Completely Resected Stage IB (>= 4 cm) - IIIA Non-small Cell Lung Cancer (NSCLC) (E1505)
Study
phs004246
-
Disentangling the Effect of Black/African Ancestry from Confounding Variables on Colorectal Cancer Biology
Study
phs004622
-
Correlative Studies in Protocol GU16-287, which Studied Gemcitabine + (Carboplatin or Oxaliplatin) + Nivolumab in Metastatic Urothelial Cancer, which Included Collaboration with CIMAC-CIDC (Cohort 1 of 3)
Study
phs004060
-
Blood and Marrow Transplant Clinical Trials Network A Trial of Single Autologous Transplant With or Without Consolidation Therapy Versus Tandem Autologous Transplant With Lenalidomide Maintenance for Patients With Multiple Myeloma (BMT CTN-0702-BioLINCC)
Study
phs004692
-
HINTS Geo-Coded Data 2013 (HINTS 4 Cycle 3)
Study
phs004208
-
Interdisciplinary Approaches for Understanding how Arsenic and Micronutrients Affect the Epigenome to Influence Spina Bifida Risk
Study
phs003733
-
Childhood Cancer Data Initiative (CCDI): Whole Genome Landscapes of Patient Derived Osteosarcoma Xenograft Models
Study
phs004232
-
Transcriptional Signatures Indicating RB Function Correlate with Response to CDK4/6 Inhibition in Endometrial Cancer
Study
phs004904
-
Effector CD4 T Cells Convert Transient Responses to KRAS-Targeted Therapy into Long-Term Durable Remissions in Pancreatic Cancer
Study
phs004509
-
NCTN: Radiation Therapy and Cisplatin with or without Cetuximab in Treating Patients with Stage III or Stage IV Head and Neck Cancer (RTOG-0522)
Study
phs004190
-
Blood and Marrow Clinical Trials Network Evaluating Corticosteroids with Mycophenolate Mofetil vs. Corticosteroids with Placebo as Initial Systemic Treatment of Acute GVHD (BMT-CTN-0802-BioLINCC)
Study
phs004840
-
Trial of Activity for Adolescent Girls (TAAG-BioLINCC)
Study
phs004741
-
FORCE Trial: Resistance Training Intervention Among Colon Cancer Patients
Study
phs003671
-
Blood and Marrow Transplant Clinical Trials Network - A Phase II Multicenter Trial of Single Autologous Hematopoietic Cell Transplant Followed by Lenalidomide Maintenance for Multiple Myeloma with or without Vaccination with Dendritic Cell/Myeloma Fusions (BMT CTN-1401-BioLINCC)
Study
phs004718
-
NCTN: A Randomized Phase III Post-operative Trial of Platinum Based Chemotherapy vs. Capecitabine in Patients with Residual Triple-Negative Basal-Like Breast Cancer following Neoadjuvant Chemotherapy (EA1131)
Study
phs004236
-
A Phase 1-2 Study of the Combination of Olaparib and Tremelimumab in BRCA1 and BRCA2 Mutation Carriers with Recurrent Ovarian Cancer (NCT02571725)
Study
phs004512
-
The Electronic Medical Records and GEnomics Network Genomic Risk Assessment (eMERGE IV)
Study
phs003905